VEGFA and systemic lupus erythematosus: This systematic review and meta-analysis has several strengths, e.g. the assessment of VEGF in SLE patients and different subgroups (active disease and presence of specific complications), the assessment of the certainty of evidence for each available endpoint, and the evaluation of associations between the effect size and specific study and patient variables.